Check out Jim Cramer's latest trading recommendations on Action Alerts PLUS.(Updates from 11:26 a.m. ET with closing information.)
NEW YORK (TheStreet) -- Here's what Jim Cramer had to say on CNBC's "Squawk on the Street" Tuesday.
He also said that the Federal Reserve's approval of JPMorgan Chase's (JPM - Get Report) capital plan means the bank can now "return a lot more money to its shareholders" and that the stock should go higher. JPM was flat at $58.26.
Cramer also said, "When Celgene (CELG) makes a deal with you, your stock flies," and that's exactly what's happening to OncoMed Pharmaceuticals (OMED - Get Report), which is ripping higher Tuesday. OMED zoomed 98% to end the day at $27.70.
At the time of publication, Action Alerts PLUS, which Cramer co-manages as a charitable trust, held shares of JPM.
To sign up for Jim Cramer's free Booyah! newsletter, with all of his latest articles and videos, please click here.
-- Written by Bret Kenwell in Petoskey, Mich.